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ABSTRACT

Bayesian Methods in
Preoperative Risk Assessment for Cardiac Surgery

by
Huey-chung Teng

Many strides have been made in the last decade to improve the accuracy of preoperative
risk estimation, particular for cardiovascular surgery. It is our goal to estimate the
preoperative risk associated with cardiac bypass surgery for patients in different risk
categories. These risk categories are determined by the Parsonett model.
The Parsonett model assigns a risk value to a range of risk factors consisting of patient
attributes and disease parameters. Logistic modeling is applied to generate a comprehensive
risk function. The database being utilized contains over 3,000 patients who have had
cardiovascular surgery within the last 5 years.
This thesis will utilize a database comprised of preoperative risk categories and their
respective surgical outcomes in order to uniformly rate institutional and surgical performance.
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CHAPTER 1

INTRODUCTION AND LITERATURE SURVEY

1.1 Problem Statement
Preoperative risk is dependent upon a wide range of patient attributes and disease
parameters which are viewed as "risk factors". It is our goal to estimate the preoperative
risk associated with cardiac bypass surgery for patients in different "overall risk"
categories. The categories are identified by the Parsonett model, which serves as the
source of the prior subjective probabilities of expiration for individual patients as shown in
Table 1.1. (See appendix)
Table 1.1 Prior Subjective Probabilities of Expiration Risk
Risk Factors
Coefficient
of Risk
sexriskn (gender) (male,female)
obesity (no,yes)
diabetic (no,yes)
hyperten (hypertension) (no,yes)
efriskno (ejection fraction) (good,fair,poor)
ageriskn (age) (0-69,70-74,75-79,80+)
reoperat (repoperation) (no,first,second,third)
preopiab (intra aorta balloon) (no,yes)
lva (no,yes)
crashptc (no,yes)
dialdepe (dialysis dependent) (no,yes)
avr (no,gradient?_120,gradient<120)
mvr (no,pressure60,pressure<60)
tvr (no,yes)
addedcab (no,yes)
smoker (no,yes)
heredity (no,yes)
hicholes (high cholesterol) (no,yes)

1

1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1

Prior Subjective
Probability (% of
Risk)
(0,1)
(0,3)
(0,3)
(0,3)
(0,2,4)
(0,7,12,20)
(0,5,10,10)
(0,2)
(0,5)
(0,10)
(0,10)
(0,7,5)
(0,8,5)
(0,3)
(0,2)
(0,1)
(0,1)
(0,1)
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1.2 Methodology

Table 1.1 has shown the prior subjective probabilities of expiration. These prior
probabilities are transformed into posterior risk values by utilizing a range of regression
procedures. This Parsonett model can be viewed as a step function which absorbs risk
contributions from the presence or absence of a risk factor.

bo+ bixi + b2xx + • • • + bkxk
bo =intercept (minimum risk)
bi = coefficient for risk factor

For example: Let x4 denote hypertension risk number then

So 0 5 104x4

Xa = 0

if patient is not hypertense

xa = 3

if patient is hypertense

3b4. Hence, the patient's risk is increased by 3b4% if he (or she) is

hypertense and is not increased at all if he (or she) is not hypertense. Then b4 is the
adjustment factor which transforms a prior risk value to a posterior risk value. This is
repeated for all remaining risk factors.
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1.3 Literature survey
1.3.1 Preoperative Risk Assessment in Cardiac Surgery:
Dose the Model Predict Risk Accurately?
—A summary of the research by Dr. F.L. Junod, et al. (1).
This risk assessment model focuses upon assessing the probability of mortality due to a
given surgical procedure as a function of:
CABG = coronary artery bypass grafting
AVR

= aortic valve replacement

MVR

= mitral valve replacement

-as well as other patient history information.
For cardiac surgery, CABG, AVR and MVR are high risk factors. Changing
methods of surgical management are probably altering risk but identifying areas for further
improvement.
A model was constructed as follows:
1. The patients were isolated into groups (severity of risk).
2. The groups were compared using a x2 test for significant difference.
3 Once the groups were determined to be significantly different from the
others, the risk was assigned to future patients who fell into a specified risk
category.
Data was then gathered on patients not previously utilized to determine the original
risk model in order to check model validity. The results of the study showed that patients
rated as high priority were indeed of higher risk.
For the surgical population reported, emergency surgical priority had a highly
significantly different risk from elective priority (p < 0.01). Operative deaths by surgical
priority are shown in Table 1.2.

Table 1.2

Operative Mortality by Surgical Priority for Patients Having Isolated
Primary CABG

Group

All Patients

Elective
Urgent
Emergent

11/533 (2.1)*
15/580 (2.6)
26/190 (13.7)

Patients with Isolated Primary CABG
2/329 (0.6)
5/450 (1.1)
7/134 (5.2)

*Numbers in parentheses are percents.

Table 1.2 shows that patients were not given an erroneously low risk. Therefore,
preoperative risk assignments is an effective method of quality assurance. Results of a
further study are given in Table 1.3.

Table 1.3 Operative Mortality by Age and Sex for Patients Having Isolated Primary
CABG
Age(yr)
<50
50-59
60-69
70
Total

All patients
0/84
2/249(0.8)*
7/348(2.0)NS**
5/232(2.2)NS
14/913(1.5)

Male
0/70
2/213(0.9)
6/250(2.4)NS
1/148(0.7)
9/681(1.3)

Female
0/14
0/36
1/98(1.0)
4/84(4.8)p<0.05
5/232(2.2)NS

*Numbers in parentheses are percents.
**NS = not significant to p < 0.05.

There was no increased risk associated with increased age. The only subset of
patients with higher risk was for women over 70 years old. So the CASS researchers
concluded that an age greater than 60 years and female sex affected operative mortality.
However, Dr. F.L. Junod and co-workers (1) support the decreased importance of age as
a determinant in the seventh and eighth decades. Only the class of women showed a
statistically significant difference in patients older than 79 years. Overall, there was no
difference in risk between men and women.
This paper devoted a great deal of time to discussing high risk factors in surgical
outcome risk. Frequently, high risk patients are all grouped together regardless of why
they are considered to be high risk. High risk patients are usually compared to low risk

ones. But this paper compared one high risk class to another one and so on. For this
reason, it is interesting and useful for our future work.

1.3.2 Analysis of Operative Mortality in Coronary Artery Surgery
1.3.2.1 Difference in Mortality from Coronary Artery Bypass Graft Surgery at Five
Teaching Hospitals
There are some possible reasons for differences in mortality from coronary artery surgery
at different hospitals. Dr. S.V. Williams and co-workers (2) use hospital discharge
abstracts and itemized bills at five hospitals in Philadelphia, PA. to measure hospital and
surgeon-specific mortality rates for patients with coronary artery bypass graft surgery and
to examine possible reasons for any differences.
Dr. S.V. Williams (2) observed differences in hospital mortality rates for 4,613
patients categorized into two groups:
1. Diagnosis related group 106 ( DRG 106) :
Patients underwent coronary artery catheterization and CABG surgery during
the same admission .
2. Diagnosis related group 107 ( DRG 107):
Patients underwent only CABG.
The hospital-to-hospital differences in mortality rates for DRG 107 were small and
not statistically significant (p = 0.572). In contrast, there were substantial differences in
hospital mortality rates for DRG 106 (p = 0.0004). Although illness severity did identify
patients who were more likely to expire, differences in severity of illness did not explain
differences in hospital- or surgeon-specific mortality rates. Dr. S.V. Williams (2) found
inconclusive evidence for patient mortality rates associated with a surgeon's clinical skills,
and, to a lesser extent, with the hospital's volume of procedures and the hospital's
organization and staffing.
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This encourages us to pursue the study of preoperative surgical risk for patients in
different " overall risk " categories. A " prior probability of mortality " may be used to
identify the primary risk groups. Hence, our work focuses upon the use of the " Parsonett
Model ". (See chapter 2)
1.3.2.2 Multivariate Discriminant Analysis of Operative Mortality From the
Collaborative Study in Coronary Artery Surgery (CASS)
The Collaborative Study in Coronary Artery Surgery (CASS) is a large multi-institutional
study of the medical and surgical treatment of coronary artery disease (CAD). In an effort
to better understand the clinical and angiographic characteristics predictive of OM, Dr.
J.W. Kennedy and associates (3) have done a multivariate discriminant analysis of
variables associated with OM.
The data file of CASS (3) contains detailed information about the clinical,
angiographic, and surgical characteristics of patients enrolled in the study. The baseline
data were controlled by physicians and trained data technicians at the time the patient was
hospitalized for coronary arteriography.
The results of this multivariate discriminant analysis of the predictors of OM are
presented for several clinical groups as shown below.
Table 1.4 Clinical Groups.
Group I

All operated patients

Group II

All CABG operations

Group III

Elective CABG operations

Group IV

Urgent or emergent CABG operations

Group V

Patients in group II divided by age

Group VI

Patients in groups II, III, and IV divided by sex

The operative mortality for the total groups of patients and various subgroups is
given in Table 1.5.

Table 1.5 Operative mortality for groups
Groups
I
II
III
IV
V
VI

No. of pts*
6,652
6,176
4,913
1,263
4,303
1,873
5,197
979

Description
All operated pts
All CABG pts
Elective CABG pts
Urgent - emergent CABG pts
CABG only, < 60 years
CABG only, 60 years
Men CABG only
Women CABG only

OM(%)
2.9
2.3
1.7
4.4
1.4
4.2
1.8
4.5

*No. of pts = Number of patients.

Clinical variables of most predictive value were age, female sex, increased heart size,
and congestive heart failure.

Angiographic variables of importance included left

ventricular wall motion abnormalities, and left main coronary disease. There were six
variables that contained the most predictive information by analysis for a group of 6,176
patients who had isolated bypass operations. They are age, left main coronary artery
stenosis 90%, female sex, left ventricular wall motion score, left ventricular end-diastolic
pressure, and rales. The risk of OM for an individual patient may be estimated with the
use of these clinical and angiographic characteristics.

1.3.3 Further Issues in Cardiac Risk Assessment for Specific Population Groups
1.3.3.1 Exclusion of the Elderly and Women From Coronary Trials. Is Their Quality
of Care Compromised ?
—Equal Access to Cardiac Treatment
Currently, 13% of the population is older than age 65 years; this percentage is expected to
increase to 21%, or 35 million people, by the year 2030 (4). The majority of US patients
with clinical manifestations of coronary heart disease are older than 65 years; more than
half of all myocardial infractions now occur in this elderly age group. Therefore,
increasing numbers of elderly individuals have changed not only the profile of the US
population, but also the demography of cardiovascular disease.

The clinical presentation, symptoms, disease severity, clinical course, and prognosis
of the more than 3.6 million elderly patients with coronary heart disease differ substantially
from those encountered at younger age and likely necessitate differences in assessment and
therapy. The mean ages of study patients in the clinical trials with and without age
exclusionary criteria were comparable, indicating potential investigator, treating physician,
societal, cultural, and elderly patient bias regarding enrollment in clinical trials of therapies
for acute myocardial infarction. Furthermore, two thirds of the US expenditures for the
care of cardiovascular illness involves patients older than 65 years of age.
Any age-based rationing of clinical care disproportionately disadvantages women
because more women than men survive to older age, and women more frequently develop
cardiovascular illness at an older age. The prognosis for women with coronary heart
disease is more ominous than that for men for both medical and surgical therapies;
women's subsequent symptomatic and functional limitations are greater. In addition, rates
of invasive cardiovascular procedures differ between the sexes, although it is not clear
whether gender differences in the use of medical care affect the outcome or prognosis of
coronary disease in women.
The high incidence of recurrent coronary events in elderly and women patients
increases the likelihood of detecting benefit (or risk) of an intervention, because of the
frequent occurrence of designated clinical trial end points. The incorporation of elderly
and women patients in clinical trials of diagnostic and management strategies has
substantial potential to define age- and gender-based differences and improve their
responses to therapies for coronary disease.
1.3.3.2 The Exclusion of the Elderly and Women From Clinical Trials in Acute
Myocardial Infarction
This paper focuses upon a range of goals: to determine the extent to which the elderly
have been excluded from trials of drug therapies used in the treatment of acute myocardial

infarction, to identify factors associated with such exclusions, and to explore the
relationship between the exclusion of elderly and the representation of women.
Patients 65 years of age and older comprise over 60% of those discharged from the
hospital with a diagnosis of acute myocardial infarction, although they constitute only 13%
of the US population. Because of the demographic shifts taking place in the US
population, the numbers of older patients suffering an acute myocardial infarction will only
continue to increase. Since women outlive men by an average of 7.5 years, they are
disproportionately represented in an elderly population. While women comprise only 24%
of those younger than age 65 years who die of acute myocardial infarction, they constitute
64% of those who die at age 85 years or older.
Dr. J.H. Gurwitz and associates (5) conducted a systematic search of the Englishlanguage literature from January 1960 through September 1991 to identify all relevant
studies of specific pharmacotherapies employed in the treatment of acute myocardial
infarction. Only trials in which patients were randomly allocated to receive a specific
therapeutic regimen or a placebo or nonplacebo control regimen were included in the
present review.
Studies were abstracted for year of publication, source of support, performance
location, drug therapies to which patients were randomized, use of invasive diagnostic
tests or therapeutic procedures, exclusion criteria, size and demographic characteristics of
the randomized study population, and principle outcome measures.
A total of 150,920 study subjects were randomized in the 214 clinical trials. The
median number of subjects for all studies was 145 (mean: 705; range: 14 to 20,768).
Information regarding the mean age of study participants was available for 75% of the
trials (n = 160) and was 57.5 ± 2.8 years. Information on the gender characteristics of
study participants was available for 89% of studies (n = 191) involving 145,388
participants, of whom 20% were female.
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Age-based exclusions are frequently used in clinical trials of medications used in the
treatment of acute myocardial infarction. Such exclusions limit the ability to generalize
findings to the patient population that experiences the most morbidity and mortality from
acute myocardial infarction.
1.3.3.3 Incidence of Silent Ischemia After Acute Myocardial Infarction
-Further Issues in Cardiac Risk Assessment
Dr. G.J. Taylor and associates (6) tested the hypothesis that silent ischemia is more
common in patients treated with thrombolytic therapy for acute myocardial infarction.
This paper focuses on determining the incidence of angina pectoris during induced
myocardial ischemia in patients who have had thrombolytic therapy for acute myocardial
infarction in comparison with angina pectoris.
Twenty-five patients with angina pectoris who were undergoing angioplasty were
compared with 30 patients having angioplasty 2 days after thrombolytic therapy for acute
myocardial infarction. During pertaneous transluminal coronary angioplasty, both study
groups had coronary artery occlusion by the balloon dilatation cather for 5 minutes.
During balloon occlusion 16 (64%) of 25 patients in the angina pectoris group
developed angina. In contrast, 9 (30%) of 30 patients in the thrombolysis group had
angina pectoris during balloon occlusion of the infarct artery (p < 0.01).

The

electrocardiographic response to ischemia and changes in pulmonary wedge pressure were
similar in the two study groups.
These results are consistent with other studies reporting that spontaneously
occurring or exercise-induced ischemia after coronary thrombolysis did not provoke
symptoms in 48% to 83% of patients. Furthermore, their suggestion that there is cardiac
sensory dysfunction after coronary thrombolysis should focus greater attention on a
symptomatic coronary artery reocclusion after thrombolytic therapy.
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1.3.4 Cardiac Risk for Specific Treatment Protocols
1.3.4.1 A Study of In-Hospital Mortality Associated With Coronary Artery Bypass
Grafting
The use of mortality rates as an indicator of the quality of medical care has raised concerns
that observed differences in mortality rates by institution may be the result of confounding
by characteristics of patient case mix, which may distort apparent rates of in-hospital
mortality and lead to false conclusions about the quality of medical care provided. Then, a
prospective regional study by Dr. G.T. O'Connor and associates (7) was conducted to
determine if the observed differences in-hospital mortality rates associated with coronary
bypass grafting are solely the result of difference in patient case mix.
This study (7) includes data from all surgeons performing cardiothoracic surgery in
Maine, New Hampshire, and Vermont. The data were collected from five regional
medical centers and from all consecutive isolated CABG surgery patients during the study
period. Data included patient demographic and historical data, body surface area, cardiac
catheterization results, priority of surgery, comorbidity, and status at hospital discharge.
This study (7) presents data for 3,055 CABG patients between July 1, 1987, and April 15,
1989.
Most of these patients (73.2%) were male. The mean age was 63 years, with a
range from 25 to 89 years. With regard to priority of surgery, 202 (6.6%) of the CABG
procedures were classified as emergent, 1,287 (42.1%) were classified as urgent, and the
remaining 1,566 (51.3%) were elective. The overall crude in-hospital mortality rate for
isolated CABG was 4.3%. The rate varied among centers (range, 3.1% to 6.3%) and
among surgeons (range, 1.9% to 9.2%). Predictors of in-hospital mortality included
increasing age, female gender, small body surface area, greater comorbidity, reoperation,
poorer cardiac function as indicated by a lower ejection fraction, increased left ventricular
end diastolic pressure, and emergent or urgent surgery. Logistic regression analysis was
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used to adjust crude in-hospital mortality rates for variation in predictors of in-hospital
mortality.
After adjusting for the effects of potentially confounding variables, substantial and
statistically significant variability was observed among medical centers (p=0.021) and
among surgeons (p = 0.025). Dr. G.T. O'Connor et al. (7) concluded that the observed
differences in-hospital mortality rates among institutions and among surgeons in northern
New England are not solely the result of differences in case mix as described by these
variables and may reflect differences which are currently unknown.
1.3.4.2 Changes in Coronary Arteriograms and Coronary Events
The Program on the Surgical Control of the Hyperlipidemias (POSCH) (8) was designed
to ascertain whether the lipid modification induced by the partial ileal bypass operation
affects the clinical course and the sequential coronary arteriograms of patients with
documented atherosclerotic coronary heart disease (ACRD). A specific design objective
of POSCH (8) was to examine the validity of the use of changes observed on sequential
coronary arteriograms as a surrogate end point for clinical coronary events.
A total of 838 patients were studied, with 417 patients randomized to the control
group and 421 to the intervention group. Of all patients, 695 had baseline and 3-year
arteriograms. The control group received American Heart Association Phase II diet
instruction and the intervention group received identical dietary instruction plus a partial
ileal bypass operation.
The Program on the Surgical Control of the Hyperlipidemias, a randomized
secondary atherosclerosis intervention trial, obtained coronary arteriograms at baseline, 3,
5, and 7 or 10 years of follow-up. Assessments of changes between pairs of coronary
arteriograms were made by two-member panels blinded to the patients' assigned treatment
and to the temporal sequence of the films. The relationship of changes between the
baseline and the 3-year follow-up arteriograms and subsequent clinical coronary events
was examined.
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Changes between the baseline and the 3-year coronary arteriographic overall disease
assessment were significantly associated with subsequent overall and atherosclerotic
coronary heart disease mortality (p < 0.01). For the combined end point of atherosclerotic
coronary heart disease mortality or confirmed nonfatal myocardial infarction, a significant
relationship between the overall disease assessment and subsequent clinical events was
found in the control group (p < 0.0001) and in the surgery group (p = 0.04). For this
combined end point, however, the control and the surgery groups were different with
respect to clinical coronary event after 3 years, stratified by the baseline to 3-year overall
disease assessment.
Coronary arteriographic changes can be used in atherosclerosis intervention trials as
a limited surrogate end point for certain clinical coronary events. This relationship is
statistically compelling for overall mortality and atherosclerotic coronary heart disease
mortality. For an individual patient, changes in the severity of coronary atherosclerosis
seen on sequential coronary arteriograms can serve as prognostic indicators for
subsequent overall or atherosclerotic coronary heart disease mortality.

CHAPTER 2

MATHEMATICAL MODELS FOR RISK ESTIMATION

2.1 Linear Regression

We wish to establish a model that estimates the risk of cardiovascular surgery (as a
percentage likelihood of fatality due to the surgical procedure). The initial model will
utilize the available data for 1,021 patients. The data is organized so that each input
variable identifies key risk contributors and quantifies their values in the form of
percentages of risk. The risk contributions are modeled to be additive and mutually
independent in the calculation of overall risk. Hence, we select a linear regression model
to estimate overall risk as shown.

= bo + bixi+ b2x2+ • • • +bkxk

where xi, x2,.. xk denote k independent variables. This is a form of linearly combining
contribution to surgical risk in order to obtain an aggregate risk value. In this model, the
goodness of fit is determined by the F statistic. The ANOVA table associated with this
multivariate regression process is shown in Table 2.1.
Table 2.1 Analysis of Variance (ANOVA)
d.f.
SS
Source
Regression
SSreg*
Residual
Totals
Corrected
*revregression
**res=residual

SSres**
SStotal
corrected

MS
SSreg / k
SSres /(n-k-1)

n-k-1
n-1

14

F ratio
F = MS ,
MSres

15

The correlation coefficient is R as shown

I SS „g

(2.1)

R=„

V

SS total corrected

where

SS regression -=

ss residual

E
E
E

SS total corrected =

The data is (xi', x2,,• • ..zki

.

-37)2

(2.2)

(y — 5.7)2

(2.3)

(y — y)2

(2.4)

We utilize the fundamental partition equation

SS total corrected = S reg S S res

(2.5)

= bo +Eboci

(2.6)

y=

(2.7)

The following models which are initially proposed:
Mortality number. =

bnix m;

where xo = 1 and k=15 or k=18

bmxm;

where xo = 1 and k=15 or k=18

m=0

Discharge status =
m=0

Mortality number and discharge status are quantitative measures of overall risk: the
former is a subjective probability assignment by the physician or surgeon; the latter is a
discrete code for the outcomes of the surgical procedure. The mortality number is a
weighted sum of risk contributions. The pre-established weights are the physician's
subjective contribution to this measure. The discharge status incorporates the discrete
nature of the dependent variable data which may be viewed as a step function (see Figure
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2.1). Therefore, logistic modeling may be useful in smoothing the risk values into a
continuous equation.

discharge status'
patient expired

1

0
i
i+1
patient survived surgery

patient number

Figure 2.1 A step function for discharge status and patient number.

2.2 General Model

Frequently, one wishes to pose a model which possesses some specific asymptotic trends.
In particular, when we wish to "smooth" out a step function, we recognize the need to
incorporate the following conditions:

lim f (x) = 0

and

x-4

lira f (x) = B

(2.8)

-)-E 00

where B is a constant, usually equal to 1. If we further require that f(x) be monotone
increasing, then we establish two key features in the model: (1) f(x) satisfies the conditions
of a distribution function (e.g., a probability distribution for 0 < B 1). (2) f(x) possesses
attributes of a function, y, which satisfies the following initial value problem.

ay
chc

= AY (B .Y)

with

y(0) = Bo

(2.9)
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We want a function whose rate of change is (a) proportional to the dependent
variable value, and (b) proportional to a constant minus the dependent value. That is

and

Y'ccY

Yicc(3-31)

(2.10)

Historically, y'ocy leads us to a well known model in population dynamics [The Malthusian
Linear Model]. Demographically, we expect however that the population growth will
level off as the maximum available space and resources are depleted. Hence y'oc(B-y)
represents a leveling off of the growth function which leads us to the previously outlined
initial value problem referred to as the logistic model. This approach allows us to smooth
a step function to a differentiable probability distribution which will model the cumulative
risk and utilize the database variable.

2.3 Logistic Modeling

Dr. Parlar and collaborators (9) have employed a logistic model to estimate the
probability, P, of lesions in some defined region, S, of the brainstem. This estimate is
obtained from an "implication factor", M, which represents a measure of malfunctioning
neural pathways in this region based upon neurological test outcomes. A region, S, is
made up of elements (voxels), allowing each neural pathway to be representable as a set of
voxels contained in S. An implication factor M for a region S then reflects summation of
individual "malfunction factors" defined for each voxel.
A sigmoid logistic model for the lesion probability, P, in region S has previously
been introduced as:

18

P = P(M)=

A

1+ Be

(2.11)

where A, B, and a are patient and disease parameters, with A as the maximum
possible lesion probability. Equation 2.11 is the solution of the initial value problem.

dP
= P'= aA(—P)(1— —)
P
dM A A
A
P(M = 0) =
1+B

(2.12a)
(2.12b)

This model is plausible because it contains intrinsic and necessary patterns in the rate
of change of lesion probability with respect to a positive net malfunction factor (i.e., the
slope of the tangent to the curve). These patterns are clear by inspection of the curve's
convexity. There is a change when M =in B/a. This point is an inflection point because
P" change sign (from positive values when M < in B/ to negative when M > In

). It is
a
clear that since P" is negative, and hence, P' is a decreasing function for M > In B/
oc • We

see that P is a monotone increasing function of M.
Let us discuss this rate of change condition in the Equation (2.11) above. The curve
approaches horizontal asymptotes: P=0 and P=A. Also observe that P and P' are well
defined for all values of M. The function P is bounded, and in fact the derivative is
bounded since, first of all,

a>0
A>0

and

(31.1)<AP'>0

(2.13)

and further, by deriving all possible inflection points, the slope of the tangent, P' achieves
e
). By computation, we see this value to
= In B/
its maximum value for P =
/a
•
be,
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P max =

a4
4

for

P

A

2

(2.14)

Thus
ae4
O<P'<—
4

(2.15)

2.4 Logistic Regression

If we allow

y= 13e-rz

(2.16)

z= b0±1biXi
i=1

(2.17)

where

then

lny=ln[3—yz
ln y = ln
or

=

p - y(bo +I bixi)

A+ ylbixi
i=i

(2.18)
(2.19)
(2.20)

Thus, we fit lny with the previous independent variables and compute A and bi for each
xi. We may then compute R2 as:
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Rz =

SS „g

=

E

E(A +
(lny,

v —v7)2
— ITY
7 inyi
N

Ilnyi

2

)

2

(2.21)

CHAPTER 3

COMPUTATION AND SUMMARY OF STATISTICAL RESULTS

3.1 Conversion of Prior Risk Values to Posterior Risk Values

We wish to determine the posterior probability of expiration due to cardiovascular
surgery, based upon a prior "cardiac risk distribution" provided by the "Parsonett Model".
These initial risk values will be adjusted so as to estimate an overall risk function (at first,
by linear approximation). This adjustment is twofold. We seek a linear combination of
"independent" risk factors as an average computation of risk. Further, since we are
utilizing regression analysis, we are minimizing the sum of squares of the errors as shown.
E[ final risk - initial risk ]2 is a minimum
over all patients

3.2 Comparison of Risk Values

The adjusted risk values incorporate actual patient survival rates for improved accuracy.
A common problem with prior estimates is that they are too conservative: actual survival
rates indicate that risk is being overpredicted for most patients, especially those in high
risk categories. Our revised estimates tend to more accurately predict risk for high risk
patients, but are not sufficiently accurate for patients where the aggregate risk value is less
than 4%. In these cases, the prior estimates should be utilized.
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3.3 Tabulated Results

We have four distinct regression models:
Model(I) Reduced Predictor/Maximum Information Model (RMM):
15

(Parsonett risk value) =

bo +

E bin
i=i

where

A=i

th risk factor (total of 15 of them).

Model(II) Reduced Predictor/No Information Model (RNM):
15

(Survival state) = bo +EN.;
i=i

where r, = i th risk factor (total of 15 of them) and 0 for survival; 1 for expiration.
Model(III) Complete Predictor/Maximum Information Model (CMM):
18

(Parsonett risk value) = bo +
i=i

where ri is the same as (1) except that 3 additional risk factors (smoker, heredity, high
cholesterol) are included.
Model(IV) Complete Predictor/No Information Model (CNM):
18

(Survival state) = bo +

E bin

The Complete Predictor Model includes 3 additional risk factors (smoker, heredity, and
high cholesterol).

The tabulated posterior risk values are shown below:
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Table 3.1 Reduced Predictor/Maximum Information Model RMM .
Risk Factors

Initial
Weight

Final

Initial

Weight

Contribution

Contribution

(Maximum

(Posterior Probability)

Risk Final

Risk

Parsonett
Number)
(Prior Prob.)
intercep

1

0.896634

0

0.896634

sexriskn (male,female)

1

1.196721

(0,1)

(0,1.196721)

obesity (no,yes)

1

0.876160

(0,3)

(0,2.62848)

diabetic (no,yes)

1

1.203874

(0,3)

(0,3.611622)

hyperten (no,yes)

1

0.968884

(0,3)

(0,2.906652)

efriskno

1

1.451194

(0,2,4)

(0,2.902388,5.804776)

1

1.045009

(0,7,12,20)

(0,7.315063

(good,fair,poor)
ageriskn
(0-69,70-74,75-79,80+)
reoperat

,12.540108,20.90018)
1

1.086016

(0, 5,10,10)
10,10)

(no,first,second,third)

(0,5.43008,10.86016
,10.86016)

preopiab (no,yes)

1

2.846297

(0,2)

(0,5.692594)

lva (no,yes)

1

1.431998

(0,5)

(0,5.187995)

crashptc (no,yes)

1

1.037599

(0,10)

(0,10.37599)

dialdepe (no,yes)

1

1.052031

(0,10)

(0,10.52031)

avr (no,gradient120

1

1.107784

(0,7,5)

(0,7.754488,5.53892)

1

1.498085

(0,8,5)

(0,11.98468,7.490425)

tvr (no,yes)

1

2.947985

(0,3)

(0,8.843955)

addedcab (no,yes)

1

0.777405

(0,1)

(0,0.777405)

,gradient<120)
mvr (no,pressure_60
,pressure<60)
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Table 3.2 Reduced Predictor/No Information Model (RNMI.
Risk Factors

Initial

Final

Initial

Weight

Weight

Contribution

Contribution

(Maximum

(Posterior

Parsonett

Probability)

Risk Final

Risk

Number)
(Prior Prob.)
intercep

1

-0.018019

0

-0.018019

sexriskn (male,female)

1

0.051789

(0,1)

(0,0.051789)

obesity (no,yes)

1

0.011205

(0,3)

(0,0.033615)

diabetic (no,yes)

1

0.016343

(0,3)

(0,0.049029)

hyperten (no,yes)

1

0.002456

(0,3)

(0,0.007368)

efriskno

1

0.015496

(0,2,4)

(0,0.02992,0.05984)

1

0.005076

(0,7,12,20)

(0,0.035532,0.06091

(good, fair, poor)
ageriskn
(0-69,70-74,75-79,80+)

2,0.10152)
1

0.036479

(0,5,10,10)

(0,0.182395,0.36479)

preopiab (no,yes)

1

0.048045

(0,2)

(0,0.09609)

lva (no,yes)

1

0.031283

(0,5)

(0,0.156415)

crashptc (no,yes)

1

0.004150

(0,10)

(0,0.0415)

dialdepe (no,yes)

1

0.010785

(0,10)

(0,0.10785)

avr (no,gradient_120

1

-0.002090

(0,7,5)

(0,-0.01463,-

reoperat
(no,first,second,third)

0.01045)

,gradient<120)
1

0.010462

(0,8,5)

(0,0.083696,0.05231)

tvr (no,yes)

1

0.057859

(0,3)

(0,0.173577)

addedcab (no,yes)

1

0.009134

(0,1)

(0,0.009134)

mvr (no,pressure60
,pressure<60)
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Table 3.3 Complete Predictor/Maximum Information Model(CMMI.
Risk Factors
Initial
Final
Risk
Initial Risk Final
Weight Weight
Contribution Contribution
(Posterior Probability)
(Maximum
Parsonett
Number)
(Prior Prob.)
intercep

1

1.142688

0

1.142688

sexriskn (male,female)

1

1.191676

(0,1)

(0,1.191676)

obesity (no,yes)

1

0.876011

(0,3)

(0,2.628033)

diabetic (no,yes)

1

1.205170

(0,3)

(0,3.61551)

hyperten (no,yes)

1

0.970243

(0,3)

(0,2.910729)

efriskno

1

1.451066

(0,2,4)

(0,2.902132,5.804264)

1

1.039467

(0,7,12,20)

(0,7.276269

(good,fair,poor)
ageriskn

,12.473604,20.78934)

(0-69,70-74,75-79,80+)
reoperat

1

1.087440

(0,5,10,10)

(0,5.4372,10.87440
,10.87440)

(no,first,second,third)
preopiab (no,yes)

1

2.875147

(0,2)

(0,5.750294)

Iva (no,yes)

1

1.424371

(0,5)

(0,70121855)

crashptc (no,yes)

1

1.035834

(0,10)

(0,10.35834)

dialdepe (no,yes)

1

1.049197

(0,10)

(0,10.49197)

avr (no,gradient?_120

1

1.094140

(0,7,5)

(0,7.65898,1.1971423)

1

1.488098

(0,8,5)

(0,11.904784,7.44049)

tvr (no,yes)

1

2.957870

(0,3)

(0,8.87361)

addedcab (no,yes)

1

0.789381

(0,1)

(0,0.789381)

smoker (no,yes)

1

-0.068366

(0,1)

(0,-0.068366)

heredity (no,yes)

1

-0.417990

(0,1)

(0,-0.417990)

hicholes (no,yes)

1

-0.160634

(0,1)

(0,-0.160634)

,gradient<120)
mvr (no,pressure60
,pressure<60)
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Table 3.4 Complete Predictor/No Information Model(CNMI.
Risk Final
Initial Final
Initial
Risk Factors
Weight Weight
Contribution Contribution
(Posterior
(Maximum
Probability)
Parsonett
Number)
(Prior Prob.)

Risk

intercep

1

-0.016471

0

(0,-0.016471)

sexriskn (male,female)

1

0.051700

(0,1)

(0,0.051700)

obesity (no,yes)

1

0.011161

(0,3)

(0,0.033483)

diabetic (no,yes)

1

0.016024

(0,3)

(0,0.048072)

hyperten (no,yes)

1

0.002874

(0,3)

(0,0.048072)

efriskno (good,fair,poor)

1

0.015180

(0,2,4)

(0,0.03038,0.06072)

ageriskn

1

0.005003

(0,7,12,20)

(0,0.035021,0.06003
6

(0-69,70-74,75-79,80+)

,0.10006)
1

0.036322

(0,5,10,10)

(0,0.18161)

preopiab (no,yes)

1

0.048239

(0,2)

(0,0.096478)

lva (no,yes)

1

0.030954

(0,5)

(0,0.15477)

crashptc (no,yes)

1

0.004120

(0,10)

(0,0.04120)

dialdepe (no,yes)

1

0.010793

(0,10)

(0,0.10793)

avr (no,gradient?_120

1

-0.002410

(0,7,5)

(0,-0.01687,-

reoperat
(no,first,second,third)

0.01205)

,gradietn<120)
1

0.010108

(0,8,5)

(0,0.080864,0.05054)

tvr (no,yes)

1

0.057633

(0,3)

(0,0.172899)

addedcab (no,yes)

1

0.010065

(0,1)

(0,0.010065)

smoker (no,yes)

1

-0.002494

(0,1)

(0,-0.002494)

heredity (no,yes)

1

0.012017

(0,1)

(0,0.012017)

hicholes (no,yes)

1

-0.020797

(0,1)

(0,-0.020797)

mvr (no,pressure_60
,pressure<60)
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3.4 Motivation

The reasons for considering 4 distinct models are as follows:
(1) Recognizing the improved estimates obtained by utilizing Parsonett risk values as
opposed to survival rates allow us to (a) assess the overall information which is present or
absent in a prior "probability of expiration" distributions; (b) determine the usefulness and
validity of the Parsonett risk model as an initial condition for future risk estimation; (c)
estimate risk values that utilize the intuition of experienced physicians as well as a
database of surgical outcomes.
(2) The risk factors denoted by smoker, heredity, high cholesterol are tested for
importance and relevance to best determine whether or not to they should be included in
future models. All 18 risk factors were chosen for specific evaluation by the consulting
physicians.

3.5 Summary of Multivariate Models

Below are the inferential statistics associated with the 4 different multivariate models.
Table 3.5 Results of All Models
Model

R2

R

F

P

I RIVIM

0.729

0.854

180.245

0.0001

II RNM

0.093

0.305

6.86696

0.0001

III CMM

0.729

0.854

150.0853

0.0001

IV CNM

0.094

0.306

5.7642

0.0001
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We see that the Parsonett model dramatically improves preoperative risk estimation
and is rich in medical information which is consistent with the information contained in the
patient database.

3.6 Analyzing the Impact of the Parsonett Model as a Prior Probability Distribution

We would like to identify the relation between the Parsonett number (as a percentage of
risk) and the surgical outcome (survival or expiration). We fit the Parsonett number with
this outcome (refereed to as "Discharge Status") in a linear model to determine the
regression and correlation coefficients.

Discharge status = bo + bi • ( Parsonett risk number)

(3.1)

= —0.04 +0.10408y

(3.2)

We find

where i is posterior risk and y is prior risk. From ANOVA Table 3.6 we get R=0.3489.
This is a measure of the improvement of the risk estimation provided by the Parsonett
prior probability function. Hence, we see the reason for having derived better models
when the Parsonett number was used in place of discharge status in the preceding
multivariate models.
Table 3.6 ANOVA for Dependent Variable = Discharge Status
Variable

d.f

estimate

R2

F

P

Intercep

1

-0.040037

0.1217279

141.233

0.0001

Mortalno

1

0.010408
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z = Discharge status = 0 for survival; 1 for expiration
y = Mortality number (Parsonett number = Prior risk value)

= -0.040037 + 0.010408y (Posterior risk value) is shown in Figure 3.1.

z
( posterior risk)

y
( prior risk)

- 0.04
Figure 3.1 Risk transformation

Table 3.7 ANOVA for Dependent Variable = Mortality number
Variable

d.f.

estimate

R2

F

P

Intercep

1

13.269019

0.1217279

141.233

0.0001

Dischsta

1

11.695894

y = Mortality number (Parsonett number = Prior risk value)
z = Discharge status = 0 for survival; 1 for expiration
9 = 13.269019 + 11.695894z (Posterior risk value) is shown in Figure 3.2.

13.27

z
Figure 3.2 Risk transformation (inverse function)
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3.7 Risk Category Histogram

24,2

14,6

0-4

5-9

10-14

15+

over al I

risk

-1.3
cl cbser ved

®

expected

oregressionmodel

Figure 3.3 Risk category histogram
In Figure 3.3:

observed = average Parsonett number for a given risk class
expected = actual % of mortality for a given risk class

regression model = posterior risk value from Equation 3.2

CHAPTER 4

CONCLUSIONS AND SUGGESTIONS FOR FUTURE RESEARCH

4.1 Conclusions

In this work we have utilized linear modeling and Bayesian methods to transform prior
cardiac surgery risk values into more reliable posterior risk estimates. The models which
incorporate both the experience of physicians and an extensive patient database have been
seen to be superior in both accuracy and determination of a patient's overall risk category.
The information contained in the Parsonett prior probability distribution has been shown
to be significant and very valuable to this process.

4.2 Suggestions for Future Research

Much future work is possible and promises to be quite valuable:
(1)The Parsonett model assigns a risk value to a range of "risk factors" consisting of
patient attributes and disease parameters. Testing individual factors for relative
importance should be explored.
(2)Piecewise linear models should be utilized to combine prior risk information provided
by experienced surgeons.
(3)Logistic modeling may be applied to generate a comprehensive risk function which is
compatible with the piecewise linear functions for each of the different risk categories.
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(4)A time series model should then incorporate the impact of improved technology and
evolution of surgical procedures in an effort to further improve the accuracy of risk and
performance estimation.
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APPENDIX
Risk Factor
Weight Disasters and Rare Conditions
Weight
Age at operation
0. None
0
0-69
0
70-74
7 CARDIAC CONDITIONS
75-79
12
80+
20
1. Left Main Disease, Unstable Angina
3
Sex
2. Ventricular Tachycardia / Ventricular Fibrillation
5
(VT/VF), aborted sudden death
Male
0
3. Shock/Cardiogenic (urinary output <10 cc/hr, mean BP 25
40 without vasopressors)
Female
1
4. Transmural Acute MI within 48 hrs
7
Ejection Fraction
5. CHF, chronic (with peripheral edema, plural effusion)
5
Good or 50%+
0
6. Pacemaker Dependent
2
Fair or 30%-49%
2
7. AR, acute (endocarditis)
10
Poor or 1%-29%
4
8. MR, Acute (endocarditis, papillary muscle rupture, etc. 10
Morbid Obesity
9. VSD, Acute
20
No
0
10. Constrictive Pericarditis
5
Yes
3
10
11. Congenital Heart Disease in adult, cyanotic
Diabetes
No
0 HEPATO-RENAL CONDITIONS
Yes
3
Hypertension
12.Renal Failure, Chronic(CR>2,w/out dialysis)
5
0
13.Renal Failure, Acute
25
No
14. Cirrhosis of liver, (serum bilirubin > 5)
10
Yes
3
Reoperation
0 PULMONARY CONDITIONS
No
First
5
15. COPD, severe
10
5
Second
10
16. Pulmonary Hypertension (mean pressure > 30)
Third
10
17. Idiopathic Thrombocytopenci Purpura (ITP)
10
Preoperative IABP
18. Endotrachial Tube, pre-operation
5
0
No
19. Asthma (peak expiratory flow rate <100)
20
2
Yes
20.
Asthma
(peak
expiratory
flow
rate
<
200)
10
LV Aneurysm
0
No
Yes
5 VASCULAR CONDITIONS
Dialysis-dependent
2
21. PVD, severe
0
No
5
22. Carotid Disease, unilateral occlusion
Yes
10
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Risk Factor
Weight Disasters and Rare Conditions
Weight
PTCA or Catherization "crash"
No
0
10
23. Carotid Disease, bilateral
Yes
10
5
24. AAA, Asymptomatic
MV procedure
10
25. Dissecting Thoracic Aneurysm
No
0
Yes
MISCELLANEOUS CONDITIONS
PA pressure>=60
8
PA pressure<60
5
5
26. Severe neurologic disorder (healed CVA,
paraplegia, muscular dystrophy, hemoparesis)
AV procedure
5
27. Diabetes, Juvenile
No
0
3
28. Hyperlipidemia (cholesterol > 300, HDL < 30)
10
Yes
29. Jehovah's Witness
Gradient>=120
7
5
30. Cold Agglutinins
2
5
Gradient<120
31. Aspirin Rx (ASA Rx)
3
TV procedure
32. Substance abuse (alcohol, drugs), severe
0
10
No
33. AIDS, active disease (HIV positive excluded)
5
Yes
3
34. Active Neoplasm (leukemia, lymphoma, etc.)
2
Added CABG
35. High-dose steroids, active
0
No
2
Yes
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